Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Context Therapeutics Inc. (CNTX) had Weighted-Average Shares Outstanding (Diluted) of 95.19M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-36.12M |
|
-- |
|
-- |
|
$39.70M |
|
$-39.70M |
|
$3.58M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-39.70M |
|
$-39.69M |
|
95.19M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
95.19M |
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$68.35M |
|
$0.03M |
|
$0.14M |
|
$68.49M |
|
$8.02M |
|
-- |
|
-- |
|
$8.02M |
|
$60.47M |
|
$60.47M |
|
$60.47M |
|
91.88M |
|
| Cash Flow Statement Financials | |
$-26.39M |
|
$-2.03M |
|
$-0.02M |
|
$94.43M |
|
$66.00M |
|
$-28.43M |
|
$1.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.73% |
|
-59.73% |
|
-52.74% |
|
-59.73% |
|
$0.66 |
|
$-0.28 |
|
$-0.28 |
|